{"schema_version":"1","generated_at":"2026-11-01T16:06:30.474Z","data_as_of":null,"url":"https://www.findmykol.com/kol/kari-ring","json_url":"https://www.findmykol.com/kol/kari-ring/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"kari-ring","name":"Kari Ring","credential":"MD","specialty":"Gynecologic Oncology","specialty_raw":"Gynecologic Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"University of Virginia Health System","institution_url":"https://www.findmykol.com/institution/university-of-virginia-health-system","city":"Charlottesville","state":"VA","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1790949600","orcid":"0000-0003-1730-4484","openalex":"A5064318427"},"summary":"Kari Ring is an Oncology physician affiliated with University of Virginia Health System. OpenAlex indexes 143 publications with 2,221 citations (h-index 25); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":143,"cited_by_count":2221,"h_index":25,"latest_activity_year":2025,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT06550791","title":"Evaluating the Anticancer Learning Circle Lifestyle Program in Endometrial Cancer Survivors","phase":"NA","status":"COMPLETED","role":"Overall official","sponsor":"University of Virginia","source_url":"https://clinicaltrials.gov/study/NCT06550791","trial_url":"https://www.findmykol.com/trial/NCT06550791"},{"nct":"NCT06089421","title":"Genetic Information Assistant in Telegenetics","phase":"NA","status":"RECRUITING","role":"Overall official","sponsor":"University of Virginia","source_url":"https://clinicaltrials.gov/study/NCT06089421","trial_url":"https://www.findmykol.com/trial/NCT06089421"}],"source":"trials"},"payments":{"company_count":6,"program_years":{"first":2021,"last":null},"rows_total":11,"shown":3,"withheld":8,"rows":[{"payer":"Medical Device Business Services, Inc.","program_year":2025,"amount_usd":1010,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1790949600"},{"payer":"Ethicon US, LLC","program_year":2025,"amount_usd":104.66,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1790949600"},{"payer":"Medical Device Business Services, Inc.","program_year":2024,"amount_usd":9230.36,"payment_count":8,"source_url":"https://openpaymentsdata.cms.gov/search?query=1790949600"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1790949600","source":"payments"},"prescribing":{"data_year":2024,"areas_total":3,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":42.1,"classes_total":1,"classes":[{"class":"Aromatase Inhibitor","setting":"prescribed","share_pct":42.1,"drugs":[{"name":"Letrozole","share_pct":100}],"max_beneficiaries":null}]},{"area":"Blood & clotting","share_pct":38.6,"classes_total":1,"classes":[{"class":"Factor Xa inhibitor","setting":"prescribed","share_pct":38.6,"drugs":[{"name":"Eliquis","share_pct":100}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":19.3,"classes_total":1,"classes":[{"class":"Serotonin-3 Receptor Antagonist","setting":"prescribed","share_pct":19.3,"drugs":[{"name":"Ondansetron Hcl","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco-25-00112","status":"verified"},{"title":"Mesonephric-like adenocarcinoma of the female genital tract: Pathologic diagnosis, clinical outcomes, and novel therapeutics","year":2025,"journal":"Gynecologic Oncology","source_url":"https://doi.org/10.1016/j.ygyno.2025.04.583","status":"verified"},{"title":"Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin–paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial","year":2024,"journal":"Annals of Oncology","source_url":"https://doi.org/10.1016/j.annonc.2024.05.546","status":"verified"},{"title":"Efficacy and safety of dostarlimab in combination with chemotherapy in patients with dMMR/MSI-H primary advanced or recurrent endometrial cancer in a phase 3, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)","year":2024,"journal":"Gynecologic Oncology","source_url":"https://doi.org/10.1016/j.ygyno.2024.10.022","status":"verified"},{"title":"Analysis of real world FRα testing in ovarian, fallopian tube, and primary peritoneal cancers","year":2024,"journal":"Gynecologic Oncology","source_url":"https://doi.org/10.1016/j.ygyno.2024.11.010","status":"verified"}],"source":"works"},"contact":{"address_1":"1240 LEE ST","city":"Charlottesville","state":"VA","zip":"229080001","phone":"434-924-5100","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1790949600","source":"identity"},"similar":[{"name":"Todd Villines","slug":"todd-villines","institution":"University of Virginia Health System","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/todd-villines","json_url":"https://www.findmykol.com/kol/todd-villines/profile.json"},{"name":"Benjamin Purow","slug":"benjamin-purow","institution":"University of Virginia Health System","specialty":"Neurology","url":"https://www.findmykol.com/kol/benjamin-purow","json_url":"https://www.findmykol.com/kol/benjamin-purow/profile.json"},{"name":"Linda Duska","slug":"linda-duska","institution":"University of Virginia Health System","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/linda-duska","json_url":"https://www.findmykol.com/kol/linda-duska/profile.json"},{"name":"Kenneth Bilchick","slug":"kenneth-bilchick","institution":"University of Virginia Health System","specialty":"Clinical Cardiac Electrophysiology","url":"https://www.findmykol.com/kol/kenneth-bilchick","json_url":"https://www.findmykol.com/kol/kenneth-bilchick/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":8,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2023-08-11","provider_certified":"2023-08-11","collected_at":"2026-10-31T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}